Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SOLIUS
Bainbridge Island, Washington, United Statessolius.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
SOLIUS has developed a medical light therapy device that uses a controlled spectrum of ultraviolet B (UVB) light to stimulate endogenous vitamin D production in the skin. The technology aims to provide the health benefits of sunlight while minimizing risks associated with UVA exposure. Devices are commercially available in Canada and the GCC region, with ongoing clinical trials and research for further expansion[1][2][3].
- Therapeutic areas
- PsychiatryEndocrinologyNeurology
- Modalities
- DeviceNon-pharmacological therapy (light therapy)
- Industry
- Therapeutic Medical Devices
02
Partnerships
Voatii Pharma LLC (distribution partner for GCC region)[3]
Beyond the preview
Go deeper on SOLIUS.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SOLIUS.